SITANOW-M 100/1000 TABS Tab-in-tab
MRP: 1,500
Packaging: 10x10
Pack Type: tab-in-tab
Composition:
Sitagliptin (100mg) + Metformin (1000mg) SR
Indication:
for the management of type 2 diabetes mellitus in adults to improve glycemic control, especially when diet, exercise, and monotherapy are insufficient.
Description:
Sitagliptin 100mg + Metformin 1000mg Sustained Release (SR) is a combination oral anti-diabetic medication used for the management of Type 2 Diabetes Mellitus in adults. This dual-action formula helps improve blood sugar control by targeting multiple pathways involved in glucose regulation.
Sitagliptin is a DPP-4 inhibitor that enhances the body’s natural incretin hormones. It increases insulin release and decreases glucagon levels in a glucose-dependent manner.
Metformin SR is a biguanide that reduces hepatic glucose production, decreases intestinal glucose absorption, and improves insulin sensitivity.
The Sustained Release (SR) technology of Metformin ensures gradual drug release, providing prolonged glucose control with reduced gastrointestinal side effects compared to immediate-release formulations.
This combination is commonly prescribed when diet, exercise, and single-drug therapy are not sufficient to maintain optimal glycemic control. It helps reduce HbA1c levels, fasting plasma glucose, and postprandial blood glucose levels.
Tags:
- Helps maintain stable blood glucose levels
- Reduces HbA1c effectively
- Improves insulin sensitivity
- Supports pancreatic beta-cell function
- Lower risk of hypoglycemia compared to sulfonylureas
- SR formulation improves gastrointestinal tolerability
- Convenient once-daily dosing (as prescribed)
Usage Information
Dosage
Take once daily with meals, preferably with the evening meal. Swallow the tablet whole. Do not crush, chew, or break. Dosage should be determined by the physician based on blood glucose levels. Regular monitoring of blood sugar and HbA1c is recommended.
Side Effects
Common side effects may include: Nausea Diarrhea Abdominal discomfort Headache Nasopharyngitis Metallic taste Serious (rare) side effects: Lactic acidosis (very rare but serious) Pancreatitis Severe allergic reactions Vitamin B12 deficiency (long-term use) Consult your doctor if symptoms persist or worsen.
Contraindications
Severe renal impairment Metabolic acidosis (including diabetic ketoacidosis) Severe liver disease Hypersensitivity to Sitagliptin or Metformin Patients undergoing contrast imaging procedures (temporary discontinuation required) History of pancreatitis (use with caution)
Availability
Sitagliptin Metformin SR tablets, Type 2 diabetes medicine, DPP-4 inhibitor with metformin, blood sugar control tablets, Metformin SR 1000mg, Sitagliptin 100mg tablet, oral antidiabetic combination, HbA1c lowering medicine, diabetes management tablet, sustained release metformin